A Phase 1b, multicenter, open-label platform study of select drug combinations in adult patients with lower risk (very low, low, or intermediate risk) myelodysplastic syndrome
- Tiong, Ing Soo (Primary Chief Investigator (PCI))
- Kennedy, Nola (Project Manager)
Project: Research